While much national attention in workers’ compensation is devoted to the cost and overprescription of opioid painkillers, doctors Steven Moskowitz and Hassan Moinzadeh assert that non-opioid pain drugs can pose many of the same problems − increased benefit spending, medical complications and potential for abuse.
Further, non-opioid pharmaceuticals cost more to the workers’ compensation system, they say. In a Paradigm Outcomes analysis of 10,000 lost-time claims, non-opioid pharmaceuticals accounted for 17% of total medical spending, compared with 15% for opioids.
Moskowitz,...
Comments